Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Anavex Life Sciences Corp. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 180
- −8 vs. Q1 2026
- Shares held
- 37.0M
- −2.99M (−7.5%) vs. Q1 2026
- Total value
- $95.8M
- −$26.8M (−21.8%) vs. Q1 2026
- New holders
- 25
- 63 more added
- Sold out
- 33
- 57 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $95.8M |
| Q1 2026 | 190 | $122.7M |
| Q4 2025 | 186 | $136.1M |
| Q3 2025 | 186 | $289.3M |
| Q2 2025 | 178 | $301.9M |
| Q1 2025 | 181 | $269.2M |
| Q4 2024 | 169 | $316.5M |
| Q3 2024 | 145 | $153.2M |
| Q2 2024 | 141 | $113.3M |
| Q1 2024 | 147 | $161.3M |
| Q4 2023 | 153 | $240.8M |
| Q3 2023 | 143 | $164.1M |
| Q2 2023 | 144 | $205.6M |
| Q1 2023 | 141 | $232.3M |
| Q4 2022 | 139 | $248.7M |
| Q3 2022 | 148 | $251.4M |
| Q2 2022 | 150 | $249.4M |
| Q1 2022 | 139 | $308.2M |
| Q4 2021 | 149 | $383.2M |
| Q3 2021 | 136 | $370.1M |
| Q2 2021 | 127 | $492.2M |
| Q1 2021 | 108 | $271.9M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Anavex Life Sciences Corp.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −1,409−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −871−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −288−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −614−100.0% | Sold out |
| Clayton Financial Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −233−100.0% | Sold out |
| Motco | 0 | $0 | 0.00% | −177−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −141−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Wealth Preservation Advisors, LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |